Key Highlights

  • Abbott Laboratories shares closed at $101.09 today, down 2.32%.
  • The decline came alongside broader weakness in the medical device and healthcare sector after CMS announced it would cancel ACA coverage for roughly 760,000 people and claw back billions in subsidies.
  • The move pressured healthcare names including Zimmer Biomet, QuidelOrtho and 10x Genomics.
  • The stock's underperformance also reflects growing investor scrutiny of Abbott's valuation, which trades at lower multiples than peers despite faster Operating Income and Revenue growth.

CMS Coverage Cancellation Weighs on Healthcare Names

Abbott Laboratories (NYSE:ABT) shares closed lower today alongside broader weakness across the medical device and healthcare sector, after the Centers for Medicare and Medicaid Services announced it would cancel Affordable Care Act coverage for roughly 760,000 people and claw back billions of dollars in subsidies. The policy move pressured a range of healthcare names beyond Abbott, including Zimmer Biomet, QuidelOrtho and 10x Genomics (NASDAQ:TXG).

Valuation Scrutiny Adds to the Pressure

The stock's underperformance also comes amid growing investor scrutiny of Abbott's valuation, which trades at lower multiples than peers despite faster operating income and revenue growth, according to recent commentary from a prominent activist Investment firm. That scrutiny arrives even as Abbott continues expanding its consumer health portfolio through initiatives such as its new Lingo glucose monitor partnership.

A Diversified Global Healthcare Company

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, operating through four core segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices. Its diverse portfolio spans generic pharmaceuticals, diagnostic testing systems, pediatric and adult nutritional products, and medical devices for cardiovascular care, diabetes management and neuromodulation, serving more than 2 billion people worldwide.